Clinical Trial: Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories
Study Type: OBSERVATIONAL
Official Title: Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer (eBC). Results of Retrospective Analysis of Seven Adjuvant Trials by the Hellenic Cooperative Oncology Group (HeCOG)
Brief Summary:
Although breast cancer remains one of the most common and fatal cancer types among women worldwide, earlier diagnosis and improved therapeutic approaches have led to decreased mortality over last years. Indeed, the use of HER2-targeted drugs has improved clinical outcomes for patients with HER2 positive breast cancer, while, on the other hand, until recently, little progress has been made for HER2-negative (IHC score 0 and 1+) patients.However, it seems that among these HER2-negative breast cancers, substantial…
Read more